Inmunoterapia & Hemopatías 2021

Registration

Status

Price

FREE

Do you want to know the next activities activities on Inmunoterapia y Hemopatías? Join our newsletter list to be updated on upcoming activities.

Information

In recent years, the use of immunotherapy has been a turning point in the fight against cancer. The use of uni or bie-specific monoclonal antibodies, antibodies capable of blocking immune-checkpoints, or the use of genetically modified T cells or NK cells designed to destroy tumor cells (CART), have led to a real revolution in cancer treatment.

Today, new therapies based on the identification of tumor neoantigenos and the development of custom therapeutic vaccines are showing very promising results. The use of immunotherapy is achieving its maximum development in hematological diseases because tumor cells are easier to come into contact with normal immune cells responsible for destruction.

Program:

• Descargar programa

Documents:

• Primera línea: Leucemia Aguda Linfoblástica (LAL) – Dra. Susana Rives
• Segunda línea: Linfomas (Hodgkin y no hodgkiniano) – Dra. Anna Sureda
• Tercera línea: Mieloma – Dra. Paula Rodríguez
• Leucemia Aguda Linfoblástica (LAL) – Dr. Valentín Ortiz-Maldonado
• Linfoma No Hodgkin (LNH) – Dra. Gloria Iacoboni
• Mieloma – Dr. Albert Oriol
• Estrategias para disminuir toxicidad de CAR T – Dr. Javier Briones
• Leucemias y linfomas T – Dr. Pablo Menéndez

Coordinators

• 

  Josep Mª Ribera

  Head of the Haematology Department at ICO Badalona

  Hospital Universitari Germans Trias i Pujol, Badalona.

  

  Josep Mª Ribera

  Head of the Haematology Department at ICO Badalona

  Coordinator of the Acute Lymphoblastic Leukaemia Group of the Spanish Haematology Treatment Programme (LALPETHEMA) of the Spanish Society of Haematology and Haemotherapy (SEHH), and head of the Haematology and Haemotherapy Department of the ICO-Hospital Germans Trias i Pujol (Badalona).

Accreditation

Activity accredited by the Consell Català de Formació Continua de les Professions Sanitàries-Comisión de Formación Continuada de Sistema Nacional de Salud. 0,8 Credits. Record: 09/029964-MD

• 
•